ixekizumab (TALTZ) (Injection) 80 mg/mL

Ixekizumab (TALTZ) 80 mg/mL injection is a prescription biologic used to treat moderate to severe plaque psoriasis and psoriatic arthritis. This interleukin-17A inhibitor helps reduce inflammation and skin symptoms. Always consult a healthcare provider before use.

Strength

80 mg/mL

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ixekizumab (TALTZ) 80 mg/mL injection is prescribed for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is also used to treat active psoriatic arthritis in adults, helping to reduce joint pain, swelling, and skin plaques. Patients often ask, 'what is ixekizumab used for' and this medication is designed for those seeking relief from chronic inflammatory conditions.

Side Effects

After starting ixekizumab (TALTZ) 80 mg/mL injection, many users notice a reduction in skin redness, scaling, and thickness over time. Some experience improved joint mobility and less discomfort during daily activities. Individual responses vary, and visible changes may take several weeks to appear.

Precautions & Warnings

Keep ixekizumab (TALTZ) 80 mg/mL injection refrigerated between 2°C and 8°C (36°F to 46°F) and protect it from light. Do not freeze or shake vigorously. Before handling, wash hands and ensure the injection site is clean to reduce the risk of infection. Discard any unused portion after use.

Avoid Interactions

Ixekizumab (TALTZ) 80 mg/mL injection may interact with live vaccines, so avoid vaccinations during treatment unless approved by a doctor. Caution is advised when using other biologics or immunosuppressants, as combining them may increase infection risk. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Visible improvements in skin symptoms may appear within 4 to 12 weeks of starting ixekizumab. Joint pain and swelling may also gradually decrease over time.

The safety of ixekizumab during pregnancy or breastfeeding has not been established. Discuss risks and benefits with your healthcare provider before use.

If you miss a dose, contact your healthcare provider for guidance. Do not take a double dose to make up for a missed injection.

No, ixekizumab is a biologic medication that targets specific proteins in the immune system rather than a steroid.

Alcohol use does not directly interact with ixekizumab, but it may affect your overall health and immune response. Discuss alcohol consumption with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.